| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | 0 |
Sells | $22,967,208 | 49 | 100 |
| Wotton Paul K | director | 0 | $0 | 1 | $152,672 | $-152,672 |
| Hagen Heidi | director | 0 | $0 | 1 | $445,770 | $-445,770 |
| Halpin Michael | Chief Operating Officer | 0 | $0 | 1 | $495,200 | $-495,200 |
| SIEGAL JONATHAN | Principal Accounting Officer | 0 | $0 | 6 | $514,469 | $-514,469 |
| ZERBE ROBERT L MD | director | 0 | $0 | 4 | $587,500 | $-587,500 |
| Mara Joseph Anthony Jr | Chief Financial Officer | 0 | $0 | 2 | $695,770 | $-695,770 |
| GILMAN STEVEN C | director | 0 | $0 | 4 | $985,195 | $-985,195 |
| MCLAUGHLIN KEVIN F | director | 0 | $0 | 4 | $1.38M | $-1.38M |
| Flynn Sean C. | Chief Legal Officer | 0 | $0 | 6 | $1.77M | $-1.77M |
| Hopper Jonathan Mark | Chief Medical Officer | 0 | $0 | 4 | $1.98M | $-1.98M |
| Colangelo Dominick | President and CEO | 0 | $0 | 17 | $14.72M | $-14.72M |
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Over the last 12 months, insiders at Vericel Corporation have bought $0 and sold $22.97M worth of Vericel Corporation stock.
On average, over the past 5 years, insiders at Vericel Corporation have bought $0 and sold $13.3M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,780 shares for transaction amount of $20,592 was made by Rubino Alan L (director) on 2018‑03‑16.
| 2025-06-02 | Sale | Hopper Jonathan Mark | Chief Medical Officer | 10,000 0.0197% | $40.09 | $400,900 | +8.75% | |
| 2025-05-15 | Sale | Colangelo Dominick | President and CEO | 14,063 0.028% | $41.53 | $584,036 | +2.69% | |
| 2025-05-14 | Sale | Colangelo Dominick | President and CEO | 14,062 0.0279% | $42.25 | $594,120 | +1.34% | |
| 2025-05-07 | Sale | MCLAUGHLIN KEVIN F | director | 7,000 0.0138% | $39.98 | $279,860 | +4.55% | |
| 2025-04-10 | Sale | Colangelo Dominick | President and CEO | 24,850 0.052% | $41.89 | $1.04M | -1.29% | |
| 2025-04-09 | Sale | Colangelo Dominick | President and CEO | 24,850 0.0511% | $41.11 | $1.02M | -6.46% | |
| 2025-03-13 | Sale | Colangelo Dominick | President and CEO | 26,592 0.0537% | $45.78 | $1.22M | -7.53% | |
| 2025-03-12 | Sale | Colangelo Dominick | President and CEO | 26,591 0.0538% | $46.31 | $1.23M | -8.27% | |
| 2025-03-03 | Sale | Hopper Jonathan Mark | Chief Medical Officer | 10,000 0.0201% | $49.53 | $495,300 | -14.46% | |
| 2025-03-03 | Sale | Hagen Heidi | director | 9,000 0.0181% | $49.53 | $445,770 | -14.46% | |
| 2025-03-03 | Sale | Halpin Michael | Chief Operating Officer | 10,000 0.0201% | $49.52 | $495,200 | -14.46% | |
| 2025-03-03 | Sale | Mara Joseph Anthony Jr | Chief Financial Officer | 9,000 0.0181% | $49.53 | $445,770 | -14.46% | |
| 2025-02-25 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 1,137 0.0023% | $52.07 | $59,204 | -18.78% | |
| 2025-02-25 | Sale | Flynn Sean C. | Chief Legal Officer | 1,669 0.0034% | $52.07 | $86,905 | -18.78% | |
| 2025-02-20 | Sale | Flynn Sean C. | Chief Legal Officer | 3,835 0.0077% | $57.32 | $219,822 | -21.28% | |
| 2025-02-19 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 1,710 0.0034% | $56.72 | $96,991 | -25.94% | |
| 2025-02-12 | Sale | MCLAUGHLIN KEVIN F | director | 7,000 0.0137% | $55.46 | $388,250 | -23.03% | |
| 2025-02-05 | Sale | ZERBE ROBERT L MD | director | 2,500 0.0053% | $62.50 | $156,250 | -29.50% | |
| 2025-02-05 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 1,092 0.0023% | $61.99 | $67,693 | -29.50% | |
| 2025-01-28 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 3,908 0.0082% | $61.99 | $242,257 | -26.75% |
| Colangelo Dominick | President and CEO | 260354 0.5172% | $11.11M | 1 | 41 | +18.13% |
| Hopper Jonathan Mark | Chief Medical Officer | 66237 0.1316% | $2.83M | 0 | 12 | |
| Hagen Heidi | director | 28650 0.0569% | $1.22M | 0 | 1 | |
| Wotton Paul K | director | 27402 0.0544% | $1.17M | 0 | 7 | |
| ZERBE ROBERT L MD | director | 26595 0.0528% | $1.13M | 0 | 14 | |
| Halpin Michael | Chief Operating Officer | 15539 0.0309% | $663,049.13 | 0 | 10 | |
| MCLAUGHLIN KEVIN F | director | 15100 0.03% | $644,317.00 | 0 | 4 | |
| Mara Joseph Anthony Jr | Chief Financial Officer | 13967 0.0277% | $595,971.89 | 0 | 2 | |
| GILMAN STEVEN C | director | 11000 0.0219% | $469,370.00 | 0 | 12 | |
| SIEGAL JONATHAN | Principal Accounting Officer | 1206 0.0024% | $51,460.02 | 0 | 10 | |
| Flynn Sean C. | Chief Legal Officer | 756 0.0015% | $32,258.52 | 0 | 12 | |
| Consonance Capital Management LP | 10 percent owner | 2232940 4.4355% | $95.28M | 0 | 1 | |
| ARMSTRONG R DOUGLAS PHD | Chairman and CEO | 573763 1.1397% | $24.48M | 2 | 5 | <0.0001% |
| MAYLEBEN TIMOTHY M | President and CEO | 133000 0.2642% | $5.68M | 9 | 0 | +21.76% |
| MICHEL GERARD J | CFO and VP, Corp. Development | 123182 0.2447% | $5.26M | 1 | 12 | +18.13% |
| CRESSWELL RONALD M | director | 40000 0.0795% | $1.71M | 2 | 0 | +3.5% |
| Hock Janet Mary | VP Global Research & CSO | 37136 0.0738% | $1.58M | 0 | 1 | |
| Brennan Gerald JR | VP Admin. and Finance, CFO | 30000 0.0596% | $1.28M | 2 | 0 | <0.0001% |
| SUDOVAR STEPHEN | director | 26900 0.0534% | $1.15M | 2 | 0 | <0.0001% |
| HAMPSON BRIAN | VP Product Develop | 18673 0.0371% | $796,776.91 | 0 | 1 | |
| DUNBAR GEORGE W JR | director | 12750 0.0253% | $544,042.50 | 3 | 0 | <0.0001% |
| Orlando Daniel | Chief Operating Officer | 12518 0.0249% | $534,143.06 | 1 | 1 | +18.13% |
| SIMS NELSON M | director | 10000 0.0199% | $426,700.00 | 1 | 0 | <0.0001% |
| FINGERLE LINDA M | 6927 0.0138% | $295,575.09 | 18 | 1 | +41.69% | |
| CAMPBELL MARY L | director | 1633 0.0032% | $69,680.11 | 6 | 0 | +26.72% |
| Rubino Alan L | director | 850 0.0017% | $36,269.50 | 1 | 0 | +14.22% |
| Durbin Scott | CFO | 0 0% | $0 | 4 | 1 | +21.07% |
$66,492,695 | 135 | 27.65% | $2.17B | |
$20,363,540 | 75 | 100.86% | $2.17B | |
Vericel Corporation (VCEL) | $1,376,668 | 53 | 18.46% | $2.15B |
$224,368,761 | 42 | 28.26% | $2.46B | |
$140,165,669 | 33 | 85.24% | $2.68B | |
$5,066,938 | 27 | 26.38% | $2.51B | |
$1,801,511 | 23 | 18.58% | $2.17B | |
$174,105,409 | 15 | 10.88% | $2.37B | |
$154,554,190 | 14 | 29.60% | $1.99B | |
$1,248,715 | 10 | 5.66% | $2.07B | |
$45,445,266 | 9 | -24.96% | $1.94B | |
$25,073,947 | 7 | -5.99% | $1.89B | |
$142,493,653 | 3 | 4.30% | $2.07B | |
$276,224 | 2 | -7.04% | $2.27B | |
$103,599,972 | 2 | -36.81% | $1.97B | |
$9,900,000 | 1 | -7.19% | $2.11B | |
$10,000,009 | 1 | 100.92% | $1.86B | |
$49,999,992 | 1 | 50.02% | $2.65B | |
$7,600,000 | 1 | -4.05% | $1.97B |
| Increased Positions | 146 | +51.05% | 4M | +7.05% |
| Decreased Positions | 123 | -43.01% | 3M | -4.99% |
| New Positions | 31 | New | 1M | New |
| Sold Out Positions | 31 | Sold Out | 424,016 | Sold Out |
| Total Postitions | 309 | +8.04% | 54M | +2.05% |
| Blackrock, Inc. | $310,905.00 | 15.96% | 7.98M | -244,614 | -2.97% | 2025-03-31 |
| Vanguard Group Inc | $135,761.00 | 6.97% | 3.49M | +1,636 | +0.05% | 2024-12-31 |
| Brown Capital Management Llc | $126,032.00 | 6.47% | 3.24M | -590,327 | -15.43% | 2024-12-31 |
| State Street Corp | $93,663.00 | 4.81% | 2.4M | -24,847 | -1.02% | 2024-12-31 |
| Invesco Ltd. | $87,176.00 | 4.48% | 2.24M | -130,080 | -5.49% | 2024-12-31 |
| Fmr Llc | $83,157.00 | 4.27% | 2.13M | -237,837 | -10.02% | 2024-12-31 |
| Conestoga Capital Advisors, Llc | $80,299.00 | 4.12% | 2.06M | -7,830 | -0.38% | 2025-03-31 |
| Congress Asset Management Co | $57,518.00 | 2.95% | 1.48M | +22,579 | +1.55% | 2025-03-31 |
| Wellington Management Group Llp | $50,203.00 | 2.58% | 1.29M | +701,064 | +119.26% | 2024-12-31 |
| Gw&K Investment Management, Llc | $49,621.00 | 2.55% | 1.27M | +30,180 | +2.43% | 2024-12-31 |